Syndax Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
SNDX chart
What traders are saying about $SNDX
Latest postsSyndax Pharmaceuticals Inc news
- Syndax Pharmaceuticals, Inc. (SNDX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance ·
- Syndax Pharmaceuticals (SNDX) Shareholder Investigation: MAXPIRe Trial Runs Out of Breath as Axatilimab Misses Its Mark
TipRanks ·
- Syndax Pharmaceuticals (SNDX) Stock Price, Chart & Analysis
www.debelegger.nl ·
- CenterBook Partners LP Makes New $5.14 Million Investment in Syndax Pharmaceuticals, Inc. $SNDX
MarketBeat ·
- Syndax Pharmaceuticals, Inc. (SNDX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syndax Pharmaceuticals, Inc.- SNDX
PR Newswire ·
- Syndax Pharmaceuticals stock: ASH to feature 19 drug abstracts
ad-hoc-news.de ·
- Why Is Syndax Pharmaceuticals (SNDX) Drawing So Much ASH 2026 Attention?
Yahoo Finance ·
- H.C. Wainwright Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $36
Moomoo ·
- Syndax Pharmaceuticals Is Down 51% Even Though Sales Rose
Simply Wall St ·
- Syndax Pharmaceuticals (NasdaqGS:SNDX) Stock Forecast & Analyst Predictions
Simply Wall St ·
Syndax Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $172.4M | $23.7M | $0 | $0 |
| Net income | -$285.4M | -$318.8M | -$209.4M | -$149.3M |
| Diluted EPS | $-3.29 | $-3.72 | $-2.98 | $-2.46 |
| Total assets (year end) | $529.7M | $724.8M | $612.9M | $497.2M |
| Cash and equivalents (year end) | $134.9M | $154.1M | $295.4M | $74.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Syndax Pharmaceuticals Inc
- Ticker
- SNDX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1395937
Frequently asked questions
What exchange is Syndax Pharmaceuticals Inc listed on?
Syndax Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol SNDX.
What industry is Syndax Pharmaceuticals Inc in?
Syndax Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Syndax Pharmaceuticals Inc headquartered?
Syndax Pharmaceuticals Inc's business address on file with the SEC is in New York, NY.
When does Syndax Pharmaceuticals Inc's fiscal year end?
Syndax Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Syndax Pharmaceuticals Inc report?
Syndax Pharmaceuticals Inc reported $172.4M in revenue for calendar year 2025, according to its SEC filings.